loading page

“A novel feasible cure for demyelinating diseases?”: not yet but here is the concept
  • Nahad Sedaghat,
  • Masoud Etemadifar
Nahad Sedaghat
Isfahan University of Medical Sciences. Email: nahad.sedaghat@gmail.com
Author Profile
Masoud Etemadifar
Isfahan University of Medical Sciences
Author Profile

Abstract

Will the people with demyelinating diseases ever be able to use CAR Treg cells to be cured, if it proves effective in the future? Probably not, considering its gigantic price. Researchers should focus on developing an affordable safe Treg-specific viral vector to produce CAR Treg’s in-vivo.  

Peer review status:Published

19 Oct 2021Published in Multiple Sclerosis and Related Disorders. 10.1016/j.msard.2021.103341